Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

I have been musing today and believe we are a long

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154912
(Total Views: 3535)
Posted On: 06/28/2024 2:38:21 PM
Posted By: Plotinus
I have been musing today and believe we are a long way away from “not many bites of the apple left.”

I think Dr. J et al are playing a game of platform molecule. With limited capital, let’s go long on cancer and choose an indication BP really doesn’t have an answer for (MSS sub population of CRC). For good measure, let’s pick a cancer we already have a clinical trial signal in and where the basic CCR5 research gives us a nod, add in the stark reality that it is the third most common cancer cause of death in the U.S. Add in a gloiblastoma study to spice the cancer play up. We already have a strong signal in TNBC, just missing breakthrough therapy status.

What about immune modulation and inflammation…yeah, let’s do that too. Reasonable numbers, N of 90, short duration to read out, primary endpoint on a well recognized clinical marker for inflammation—CRP, for which we already have clinical trial impact results elsewhere. Inflammation is the nexus of a whole host of human conditions that go well beyond HIV.

Neurodegenerative diseases blowing a huge hole in families lives…yeah, let’s kick the tires on Alzheimer’s disease also, investigator initiated trial on their dime, also short duration. No BP has touched AD meaningfully. BP thought aduhelm would be a star but clinicians are not ordering it and for good reasons.

Dr Jay is painting a masterpiece: platform molecule. I can see the outline sketched in; when the color gets added it may skyrocket in value, much like fine art. A year from now we can look back with hindsight and marvel at the vision.


(27)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us